FDA Approves Moderna’s New COVID-19 Vaccine

Contact Your Elected Officials

The vaccine’s design differs from Spikevax, Moderna’s shot that has been available.

The Food and Drug Administration has approved Moderna’s next-generation COVID-19 vaccine.

The FDA licensed the vaccine for adults aged 65 and up as well as people aged 12 to 64 who have at least one condition that puts them at higher risk for severe COVID-19, the agency said on May 31. The vaccine is meant for “active immunization to prevent” COVID-19 for people who have been previously vaccinated with any COVID-19 vaccine.

“The FDA approval of our third product, mNEXSPIKE, adds an important new tool to help protect people at high risk of severe disease from COVID-19,” Stéphane Bancel, Moderna’s CEO, said in a statement.

People who suffered a severe allergic reaction after receiving any Moderna COVID-19 vaccine, or after receiving any ingredient of mNEXSPIKE, should not get the new vaccine, the FDA said in a package insert.

The vaccine, also known as mRNA-1283, utilizes messenger ribonucleic acid (mRNA), just like Moderna’s already-available COVID-19 vaccine, Spikevax. But it contains just 10 micrograms of mRNA per dose, compared to 50 micrograms in the available vaccine.

Moderna scientists have said that the new vaccine encodes epitopes, or portions of the COVID-19 spike protein, rather than the full-length spike protein.

In a clinical trial of 11,417 people, about half of whom received mNEXSPIKE, the immunogenicity triggered by the new vaccine was the same or better than that prompted by Spikevax, the company told a government advisory panel in April. A lower percentage of mNEXSPIKE recipients contracted COVID-19, and severe COVID-19, the company said.

Other clinical and nonclinical data support the new vaccine, Moderna told a government advisory panel in April.

“What remains consistent throughout all those investigations is this consistent pattern that mRNA 1283 outperforms Spikevax in terms of its ability to induce higher neutralizing antibodies,” Bishoy Rizkalla, a Moderna official, told the committee.

Moderna has not yet published the results in a journal, according to ClinicalTrials.gov, a government database.

FDA officials announced earlier in May that the regulator would only approve COVID-19 vaccines if companies provided clinical trial data showing the shots provided protection against symptomatic COVID-19 and other clinical endpoints.

The exceptions were for elderly adults and people with underlying risk conditions putting them at higher risk of severe COVID-19 outcomes, as defined by the Centers for Disease Control and Prevention. Those conditions include diabetes and obesity.

By Zachary Stieber

Read Full Article on TheEpochTimes.com

The Epoch Times
The Epoch Timeshttps://www.theepochtimes.com/
Tired of biased news? The Epoch Times is truthful, factual news that other media outlets don't report. No spin. No agenda. Just honest journalism like it used to be.

Kamala, Please Run Again

Kamala Harris hinted she wants to run for President in 2028, despite poor poll numbers and her loss in 2024. If she runs, the big winners will be the GOP.

Rosie O’Donnell vs. Her Therapist

Rosie O’Donnell's therapist attempted to artfully introduce to her client to the possibility that Rosie's outrage might be performative. It didn’t take.

Hamas’s Stubborn Grip on Arms Signals No Desire for Genuine Peace

Hamas’s rhetoric reflects its founding ideology, prioritizing armed resistance over civilian welfare or diplomatic progress.

Off the radar

In the longstanding and brutal ledger of religious persecution, Nigeria now occupies its own grim chapter with its enduring pogrom against Christians.

The New Jackboots? A Wake-Up Call on Antifa and Fascism

An analysis of whether Antifa truly opposes fascism by comparing its tactics and behavior to historical signs and movements of fascist regimes.

Amazon to Cut 14,000 Corporate Jobs Amid AI Push

Amazon is cutting about 14,000 corporate jobs to streamline management, reduce bureaucracy, and focus more on AI and other key priorities.

Louisiana GOP State Lawmaker Announces Run Against Incumbent U.S. Senator

Louisiana Rep. Julie Emerson launches a campaign against Sen. Bill Cassidy, entering the state’s first Republican primary race in 50 years.

Trump Says His MRI Test Performed at Walter Reed Was ‘Perfect’

“I did,” Trump confirmed. “I got an MRI. It was perfect. I gave you the full results. We had an MRI, in the machine … the whole thing.”

Fox News to Air First TV Interview With Erika Kirk Following Husband’s Assassination

Erika Kirk, new CEO of Turning Point USA, will give her first TV interview next month, two months after the assassination of her husband, Charlie Kirk.

Trump, Japanese PM Sign Critical Minerals, Rare Earths Deal

The U.S. president visited Tokyo on the second leg...

Trump Hikes Canada’s Tariffs by 10 Percent for Not Pulling Anti-Tariff Ad Immediately

Trump announced he will increase tariffs on Canada by 10% after ad by provincial government of Ontario misrepresented President Reagan’s speech on tariffs.

Trump Rolls Back Emissions Rules on Copper Smelters

President Trump issued a proclamation aimed at reversing a Biden-era environmental rule that enforced stricter air emission standards on copper smelters.

Donor Gives $130 Million to Cover Shortfall in Troop Pay During Shutdown

Trump announced on Oct. 23 that an anonymous donor sent $130M to cover military pay during the ongoing government shutdown.
spot_img

Related Articles

Popular Categories

MAGA Business Central